Evidence map›Paper›PMID 26579596›Full record

ReviewAnnals of the New York Academy of Sciences2015

Central tolerance to self revealed by the autoimmune regulator.

Alice Y Chan, Mark S Anderson

Abstract readReview
In one paragraph

Review in Annals of the New York Academy of Sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Review
  2. Comparison of Shared Class I HLA-Bound Noncanonical Neoepitopes between Normal and Neoplastic Tissues of Pancreatic Adenocarcinoma.Clinical cancer research : an official journal of the American Association for Cancer Research · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. What can we learn fromJournal of scleroderma and related disorders · 2018
    Review
  15. Polyglandular autoimmune syndromes.Journal of endocrinological investigation · 2018
    Review
  16. Review
  17. Twenty Years of AIRE.Frontiers in immunology · 2018
    Review
  18. Article
  19. Review
  20. Association BetweenIn vivo (Athens, Greece)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Alice Y ChanDiabetes Center.
Mark S AndersonDiabetes Center.

Funding

Thymic medullary epithelial cell turnover and control of immune toleranceR01AI097457 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ANDERSON, MARK S · 2012 to 2016
$1.9M
Developing eTACs as a Novel Method of Tolerance in Type 1 DiabetesR01DK101622 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ANDERSON, MARK S · 2014 to 2018
$1.7M
NIAID NIH HHS R01 AI097457NIDDK NIH HHS R01 DK101622
6 · The paper itself

Abstract

The autoimmune regulator (Aire) was initially identified as the gene causing multiorgan system autoimmunity in humans, and deletion of this gene in mice also resulted in organ-specific autoimmunity. Aire regulates the expression of tissue-specific antigens (TSAs) in medullary thymic epithelial cells (mTECs), which play a critical role in the negative selection of autoreactive T cells and the generation of regulatory T cells. More recently, the role of Aire in the development of mTECs has helped elucidate its ability to present the spectrum of TSAs needed to prevent autoimmunity. Molecular characterization of the functional domains of Aire has revealed multiple binding partners that assist Aire's function in altering gene transcription and chromatin remodeling. These recent advances have further highlighted the importance of Aire in central tolerance.

Indexed as

Immune ToleranceAIRE ProteinAnimalsChromatin Assembly and DisassemblyHumansMicePolyendocrinopathies, AutoimmuneThymus GlandT-Lymphocytes, RegulatoryTranscription FactorsTranscription, GeneticAIRE ProteinTranscription FactorsAireAPS-1autoimmunitymTEC

Identifiers

PMID26579596
PMCPMC4654700

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.